International Assets Investment Management, LLC Inmune Bio, Inc. Transaction History

International Assets Investment Management, LLC

$36.5 Billion
Q3 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2021 Jul 14, 2021	SELL	$9.29 - $19.33 $6,502 - $13,530	-700 Closed	0 $0
Q4 2020 Jan 22, 2021	BUY	$7.51 - $17.22 $5,257 - $12,054	700 New	700 $12.1 Million

Others Institutions Holding INMB

# of Institutions

Shares Held

5.92M

Call Options Held

243K

Put Options Held

46.4K

Black Rock Inc. New York, NY

813K
Shares

$3.59 Million
0.0% of portfolio
Praetorian Pr LLC Rincon, PR

781K
Shares

$3.45 Million
1.64% of portfolio
Vanguard Group Inc Valley Forge, PA

721K
Shares

$3.19 Million
0.0% of portfolio
Cvi Holdings, LLC Wilmington, DE

596K
Shares

$2.64 Million
45.87% of portfolio
Raymond James Financial Services Advisors, Inc. St. Petersburg, FL

369K
Shares

$1.63 Million
0.0% of portfolio

View Full List

About Inmune Bio, Inc.

Ticker INMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,946,000
Market Cap $79.3M
Description
INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on tr...

More about INMB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of International Assets Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on International Assets Investment Management, LLC with notifications on news.

Account